Alan Prem Kumar
Impact in
- Toxicology top 0.02%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Natural product bioactivities and synthesis 18
- Circular RNAs in diseases 12
-
- Cancer-related molecular mechanisms research 23
- MicroRNA in disease regulation 20
- Co-authors
- Gautam Sethi (136 shared papers)Muthu K. Shanmugam (62 shared papers)Frank Arfuso (38 shared papers)Kwang Seok Ahn (47 shared papers)Anupam Bishayee (13 shared papers)Xiaoyun Dai (11 shared papers)Benny K.H. Tan (7 shared papers)Kam M. Hui (26 shared papers)
- Journals
- Biomolecules (11 papers)International Journal of Molecular Sciences (11 papers)Cancer Letters (10 papers)Cancers (9 papers)Oncotarget (9 papers)
- Partner nations
- SingaporeUnited StatesAustralia
In The Last Decade
Alan Prem Kumar
248 papers receiving 19.5k citations
Alan Prem Kumar's Hit Papers
Peers
Comparison fields: 5 of 169
- Toxicology 1.3k
- Cancer Research 3.7k
- Complementary and alternative medicine 1.7k
- Geriatrics and Gerontology 571
- Molecular Medicine 849
Countries citing papers authored by Alan Prem Kumar
This map shows the geographic impact of Alan Prem Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Prem Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Prem Kumar more than expected).
Fields of papers citing papers by Alan Prem Kumar
This network shows the impact of papers produced by Alan Prem Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Prem Kumar. The network helps show where Alan Prem Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Prem Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of Resveratrol in Cancer Therapy Hit paper breakdown → | 2017 | 621 |
| 2 | Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors Hit paper breakdown → | 2014 | 555 |
| 3 | Dual role of autophagy in hallmarks of cancer Hit paper breakdown → | 2017 | 452 |
| 4 | Emerging role of exosomes in cancer progression and tumor microenvironment remodeling Hit paper breakdown → | 2022 | 428 |
| 5 | Thymoquinone: Potential cure for inflammatory disorders and cancer Hit paper breakdown → | 2011 | 426 |
| 6 | 2015 | 400 | |
| 7 | Antioxidant response elements: Discovery, classes, regulation and potential applications Hit paper breakdown → | 2018 | 379 |
| 8 | 2015 | 298 | |
| 9 | 2013 | 277 | |
| 10 | 2011 | 273 | |
| 11 | 2019 | 263 | |
| 12 | 2012 | 248 | |
| 13 | 2013 | 236 | |
| 14 | 2016 | 234 | |
| 15 | 2017 | 232 | |
| 16 | 2014 | 230 | |
| 17 | 2018 | 199 | |
| 18 | 2016 | 196 | |
| 19 | 2021 | 190 | |
| 20 | 2012 | 187 |
About Alan Prem Kumar
Alan Prem Kumar is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Immunology, having authored 253 papers that have together received 19.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (27 papers), Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (20 papers), Natural product bioactivities and synthesis (18 papers), Bioactive Compounds and Antitumor Agents (17 papers), Cancer Mechanisms and Therapy (17 papers), Autophagy in Disease and Therapy (12 papers) and Circular RNAs in diseases (12 papers). The work is most often cited by research in Toxicology (1.3k citations), Cancer Research (3.7k citations), Complementary and alternative medicine (1.7k citations), Geriatrics and Gerontology (571 citations) and Molecular Medicine (849 citations). Alan Prem Kumar has collaborated with scholars based in Singapore, United States and Australia. Frequent co-authors include Gautam Sethi, Muthu K. Shanmugam, Frank Arfuso, Kwang Seok Ahn, Anupam Bishayee, Xiaoyun Dai, Benny K.H. Tan, Kam M. Hui, Kodappully Sivaraman Siveen and Milad Ashrafizadeh. Their work appears in journals such as Biomolecules, International Journal of Molecular Sciences, Cancer Letters, Cancers and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.